P1010485
Website 20logo

Sisu Global Health

The medical device company for emerging markets. Sisu's first product, Hemafuse, is a surgical tool to recycle blood from internal bleeding.

  • Stage Full Product Ready
  • Industry Medical Devices and Equipment
  • Location Baltimore, MD, US
  • Currency USD
  • Founded February 2014
  • Employees 12
  • Incorporation Type C-corp
  • Website sisuglobal.health

Company Summary

Sisu Global designs medical devices that can operate anywhere there is a surgeon, from a large hospital in an emerging market to a combat zone. With 5 technologies in its portfolio, Sisu is proving its model with Hemafuse: a handheld autotransfusion device that addresses chronic blood shortages globally. Hemafuse is currently sold in Africa ($955k revenue); the first step of an expansion strategy focused on emerging markets and military.

Team

  • Gillian Henker manages Sisu’s products and technical strategy. She is the primary inventor of Hemafuse. Gillian was named Baltimore’s “ Technologist of the Year.”

    Gillian previously founded a medical device design firm for Ghana. She is published in the International Journal of Gynecology and Obstetrics and presented at the Appropriate Healthcare Technologies for Developing Countries Seminar in London.

  • Carolyn is a two-time founder/CEO with a proven track record of execution. She is a Forbes 30 under 30, has raised over $3M of investment and built a global company.

    Prior to Sisu, Carolyn founded an organization working with rural mobile clinics in India, featured in Entrepreneur Magazine and Business Insider. Carolyn was named Entrepreneur of the Year for her first company while receiving her Engineering Degree at University of Michigan.

  • Sajju enables the development of Sisu's operations and business strategy. He is a serial entrepreneur, mentor and teacher with twenty years of senior management experience in industries such as healthcare (Embrace), polymers, management consulting, and renewal energy (D.Light), etc.

    His ventures have been featured on BBC, CNBC, CNN, Wall Street Journal. He is an alumnus of the Harvard Business School and the University of Iowa.

Advisors

  • Default avatar
    Dr. Mark Popovsky
    Past Chief Medical Officer of Haemonetics
    Unconfirmed
    7e5fc0eb 6c72 4a49 aa80 f397a8fb6199
    Vice President of Global Services, AABB
    Default avatar
    Dr. Jonathan Waters
    Chief Anesthesiologist at Magee Women's Hospital
    Unconfirmed
  • Default avatar
    Dr. Paul Ness
    Director of Transfusion Medicine at Johns Hopkins University
    Unconfirmed
    Default avatar
    Dr. Nichodemus Gebe
    Unconfirmed

Previous Investors